Liaoning: 6726 drugs were removed from the network, and not to participate in the collection!

On January 18th, 6,726 drugs were cancelled, meaning that at least in some parts of the public hospital market, the drugs will not be able for sale.
1, 6726 drugs were removed from the network, and may not participate in the collection of January 15, Liaoning Province, drugs and medical supplies centralized procurement network issued "on the cancellation of 6726 drugs online procurement notice."
notice said that in accordance with the relevant provisions of the Notice on the Proposed Cancellation of the Purchase of Drugs Without Purchase Records, it was decided to cancel the online procurement of 6,726 drugs without purchase records for publicity and independent applications by relevant enterprises.
regulations, the 6,726 drugs and their corresponding production enterprises will not be allowed to participate in the 2021 Liaoning Province organized drug centralized procurement activities.
At the same time, 4,707 pharmaceutical enterprises, through their own applications to retain the qualification of the network, but these drugs within one year may not carry out price and network, remove the network changes, a year later if there is still no procurement record will be directly disqualified from the network procurement.
According to combing, Liaoning Province this time to remove more than 6000 drugs hanging network qualification, involving more than 3000 pharmaceutical companies, involving a variety of also have a lot of commonly used drugs, such as chlororetatin tablets, cold clear capsules, ammonia jaundium tablets, hexa-flavored yellow pills, injection of azithromycin, ViC silver warp tablets and so on.
this large-scale drug withdrawal network originated from the Liaoning Province, medicine and supplies collection leadership group office issued a "notice on the proposed cancellation of the purchase of drugs without purchase records."
The above-mentioned notice indicates that, in order to further do a good job in the centralized procurement of drugs to ensure the effective clinical demand for drugs, it is proposed to cancel the purchase of 11433 drugs recorded as "0" (by distribution completion amount) of the drug centralized procurement platform in Liaoning Province between 0:00 on February 15, 2019 and 24:00 on February 14, 2020.
2, multi-province opening hanging network drugs normalization and retreat is not difficult to see, no procurement records are the above-mentioned drugs were eventually removed from the network of the core reasons.
, in addition to Liaoning Province this large-scale withdrawal of the network, other provinces have been targeted at non-tradable drugs, such as Zhejiang, Shanghai.
2020, Zhejiang Pharmaceutical Purchase Platform issued the Notice on the Announcement of Long-Term Non-Traded Products Exiting Online Trading on October 20 and November 12, respectively.
According to Cypress Blue statistics, Zhejiang two batches of a total of 2712 non-traded drugs, involving amoxilin capsules, azithromycin capsules, aspirin tablets, anaeba tablets, octogenone mother pills, plate blue root particles, ibuprofen tablets, ginseng injections, famotin tablets and other common drugs.
, April 24, 2020, Shanghai Sunshine Pharmaceutical Procurement Network issued two documents in succession, indicating that the Shanghai Pharmaceutical Institute will regularly close the procurement status of drugs that have not been purchased in a year.
, a total of 2,181 drugs were suspended in Shanghai, including libawelin,acid sidnafil, tadalaf, children's amphetamine particles, children's aminophen particles, plate blue root particles, wind-proof holy pills, nitrate glycerin and so on.
, the withdrawal of drugs is mainly divided into enterprise active and passive two kinds.
Generally speaking, pharmaceutical companies actively apply for the withdrawal of the network and commitment to unified nationwide non-supply reasons are mainly production line transformation, rising costs, raw material shortage, shutdown and other reasons;
is worth noting that with the reform of drug recruitment platform in various provinces, the online drug will face a more normal adjustment in price, qualification, procurement volume and so on.
attached: a list of products that are partially disqualified from the Internet